Accretion Nutraveda Ltd intimated a board meeting on May 8, 2026 to approve audited FY26 financial results.
The disclosure is a mandatory regulatory filing under SEBI LODR Regulation 29.
No preliminary financial figures, guidance, or other agenda items were disclosed in the intimation.